SEC Form D · filed February 17, 2022
ADIAL PHARMACEUTICALS, INC
Location
CHARLOTTESVILLE, VA
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (26)
Kevin W. Schuyler, Cfa · Charlottesville, VADirectorJames K. Anderson · Charlottesville, VADirectorTony W. Goodman · Charlottesville, VADirectorJames W. Newman, Jr · Charlottesville, VADirectorRobertson H. Gilliland · Charlottesville, VADirectorBankole A. Johnson · Charlottesville, VAExecJoseph M. Truluck · Charlottesville, VAExecWilliam B. Stilley, Iii · Charlottesville, VAExec · DirectorCary W. Claiborne · Charlottesville, VAExec · DirectorSever Totia · New York, NYDirectorPeter Feld · New York, NYDirectorMike Kerns · Playa Vista, CADirectorKweli Washington · New York, NYDirectorGina Mondo · Norwich, CTExec · DirectorJesse S. Jacobs · Playa Vista, CADirectorJason Bergsman · Playa Vista, CAExecW. C. Mccollum · Los Angeles, CAExecUrsula Newman · London, United KingdomExecThomas Scriven · Golden, CODirectorMatthew Davis · Purcellville, VADirectorFred Ausubel · Allston, MAExecIsaac Stoner · Allston, MAExec · DirectorCory Brown · Nashville, TNDirectorLauren Smith · Nashville, TNDirectorKiran N. Bhatraju · Shepherdstown, WVDirectorCary W. Claiborne · Charlottesville, VAExec · Director Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗